# A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

> **NCT05730621** · PHASE4 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 68 (actual)

## Conditions studied

- Sarpogrelate
- Blood Viscosity
- Peripheral Arterial Disease
- Coronary Artery Disease

## Interventions

- **DRUG:** Sarpogrelate Sustained Release/Aspirin
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT05730621
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-11
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-02-28
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05730621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05730621, "A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05730621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*